Lumateperone for the prevention of relapse in patients with schizophrenia: results from a double-blind, placebo-controlled, randomized withdrawal, phase 3 trial

Neuroscience Applied 2026 Open access

Read full text

Authors: S. Durgam, W.R. Earley, S.G. Kozauer, J. Lin, Hassan D. Lakkis, T Escher, G. Maddirevula, C.U. Correll

DOI: 10.1016/j.nsa.2025.106338

Cited by: 0

Fields of Study & Subjects

Schizophrenia research and treatment Tryptophan and brain disorders Pharmacological Receptor Mechanisms and Effects